FDA Inspection 791165 — Carter BloodCare - Arlington

Carter BloodCare - Arlington — FEI 1677509

The FDA completed an inspection of Carter BloodCare - Arlington on July 18, 2012 in Arlington, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
July 18, 2012
Fiscal Year
2012
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Arlington, TX (United States)